Drug Shortage Report for SANDOZ RABEPRAZOLE

Last updated on 2019-05-07 History
Report ID 75511
Drug Identification Number 02314185
Brand name SANDOZ RABEPRAZOLE
Common or Proper name RABEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 20MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 3X10 / Plq
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-02-04
Estimated end date 2019-05-06
Actual end date 2019-04-29
Shortage status Resolved
Updated date 2019-05-07
Company comments Available in format of 100Tab and 500Tab
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-05-07 French Compare
v7 2019-05-07 English Compare
v6 2019-03-13 French Compare
v5 2019-03-13 English Compare
v4 2019-03-13 French Compare
v3 2019-03-13 English Compare
v2 2019-02-12 French Compare
v1 2019-02-12 English Compare

Showing 1 to 8 of 8